Introduction {#s0005}
============

Mousepox is an acute exanthematous disease of mice caused by the orthopoxvirus (OPV) ectromelia virus (ECTV) that in the past century affected laboratory mouse colonies worldwide ([@bib18; @bib20; @bib35]). ECTV, like variola virus (VARV), the causative agent of smallpox, has a narrow host range and causes a severe disease with skin lesions in the later stages of the infection and a high mortality rate ([@bib18]). Mousepox was first described in 1930 in Hampstead (United Kingdom) as an infectious disease of mouse associated with high mortality and amputations in mice recovered from infection ([@bib35]). Following the identification of ECTV-Hampstead, ECTV has been isolated in temporally and geographically different laboratory mousepox outbreaks. ECTV-Moscow is a highly virulent strain isolated in Moscow in 1947 and extensively used in pathogenesis studies, and ECTV-Ishibashi, isolated in Japan in 1966, was used in the initial ECTV studies ([@bib4; @bib7; @bib27]). Several important mousepox outbreaks occurred in the USA between the seventies and the eighties. As a consequence, tens of thousands of laboratory mice were sacrificed and millions of dollars were lost in biomedical research ([@bib30]). ECTV-NIH79 was a virulent strain isolated in 1979 at the National Institutes of Health (NIH) in Bethesda, Maryland (USA) ([@bib4]). In the same period, various outbreaks were reported in biomedical research institutions in Saint Louis, Chicago, Minneapolis and Salt Lake City ([@bib16; @bib28; @bib55]). Because the clinical signs of mousepox are not evident in resistant mouse strains, ECTV infections could have been present in colonies for long periods before their identification in animal house facilities in USA. The destruction of entire mouse colonies was not always satisfactory to control mousepox spread ([@bib55]). In order to fight this continuous threat, working with live ECTV was prohibited in the USA ([@bib21]). In 1995, the virulent strain ECTV-Naval caused an outbreak in the laboratory mouse colony of the US Naval Medical Research Institute in Bethesda, Maryland (USA) ([@bib15]). The outbreak caused devastating effects and ended with the sacrifice of thousands of mice, affecting more severely the BALB/c mice ([@bib15]). The last outbreak of mousepox was reported in 1999 at the Weill Medical College of Cornell University in New York (USA), and was successfully contained and eradicated from the animal house facility ([@bib30; @bib31]). Contrary to initial speculations about the existence of a natural reservoir for this virus within the USA, it was found that the Cornell University outbreak originated from an injection of mice with a contaminated commercial mouse serum imported in 1995 from China, and the same origin was speculated for the outbreak in Bethesda that occurred four years earlier ([@bib30; @bib31]). ECTV outbreaks have no longer been reported ([@bib26]), probably due to improved housing conditions of laboratory mouse colonies and routine testing of the health status of mouse colonies. Nearly a century after the first ECTV description, it is intriguing that this virus has never been isolated from a mouse or rodent in nature, and its natural reservoir remains unknown ([@bib21]). The only exception was a report describing a putative ECTV infection in field mice in Germany in 1962. This disease could be transmitted by footpad inoculation to laboratory white mice and produced typical symptoms of ECTV infection, including skin lesions, foot inflammation and amputation ([@bib24]). However, the virus was not isolated and the presence of ECTV was not confirmed by molecular techniques.

The growing fear of the possible use of VARV as a bioterrorist weapon causing an epidemic in the human population that is no longer vaccinated against the disease prompted the need for the development of safer smallpox vaccines ([@bib51]). Moreover, OPV zoonoses have increased in recent years; monkeypox virus (MPXV) may occupy the niche vacated by VARV in Africa and cowpox virus (CPXV) is transmitted to humans by domestic animals and occasionally wild rodents in Europe ([@bib19; @bib22; @bib56]). The major limitation for the improvement of the current repertoire of poxvirus vaccines is the lack of accessible human OPV infections for clinical efficacy trials. The genetic similarity of ECTV to VARV, CPXV and MPXV, together with the convenience of a laboratory mouse model, underscores the utility of mousepox as a model for the study of OPV infections ([@bib11]).

The recent development of next generation sequencing technologies has had a pronounced impact on virology providing a fundamental tool for sequencing large viral genomes ([@bib1; @bib29; @bib36; @bib37; @bib38; @bib41]) for metagenomic studies of viral communities ([@bib33; @bib43]) and also for the identification of new viruses and pathogens ([@bib42]). In spite of the relevance of the mousepox model, only two ECTV genomes have been sequenced: ECTV-Moscow and Erythromelalgia-related poxvirus (ERPV), an ECTV strain isolated in China from throat specimen of individuals affected by erythromelalgia, a vascular disease of extremities and characterized by hyperthermia and vasodilatation ([@bib14; @bib39; @bib60; @bib61]). Here we report the sequence of the ECTV-Naval and ECTV-Cornell genomes determined by three different sequencing technologies (Sanger, 454-Roche and Illumina) and define the virulence of these isolates in susceptible mice.

Results {#s0010}
=======

Plaque purification of ECTV-Naval.Cam {#s0015}
-------------------------------------

The plaque-purified ECTV-Naval.Cam stock was obtained after three rounds of plaque purification of a single plaque derived from the spleen of a BALB/c mouse infected with the original stock of the Naval Medical Research Institute outbreak (Bethesda, Maryland, USA) ([@bib15]). The virulence in susceptible BALB/c mice of ECTV-Naval.Cam is similar to that of the original uncloned stock, indicating that the plaque-purified virus has not been attenuated and is representative of the parental virus isolate (data not shown). ECTV-Naval.Cam is referred in the text as ECTV-Naval.

Sequencing of the ECTV-Naval genome {#s0020}
-----------------------------------

The genome of ECTV-Naval has been sequenced by three different sequencing technologies: Sanger, 454-Roche and Illumina. Sequences obtained by Sanger (5810 reads with an average length of 536 bp) were assembled into five contigs accounting for 202 Kbp. Further 42 reads were obtained to close gaps and to raise the quality of low coverage regions. Finally, a contiguous linear sequence of 207,620 bp with 13× coverage was attained ([Table 1](#t0005){ref-type="table"}). The leftmost nt was an arbitrarily designated base one. The ITR of the genome contains the OPV specific structures: the hairpin loop, the concatemer resolution motif, two sets of direct repeats (DRI and DRII) and the non-repetitive I (NRI) and NRII sequences flanking DRI. The DRI of the ECTV-Naval genome, as for ECTV-Moscow, is formed by a unique sequence of 68 bp, in comparison with the 69 bp sequence repeated 2.3× of ERPV ([@bib14; @bib39]). DRII contains an 85 bp sequence repeated 19.4×, instead of 10.4× found in the ECTV-Moscow and ERPV genomes (data not shown) ([@bib14; @bib39]). A third set of direct repeats, located in the central region of the genome (DRIII), contained a 24 bp ("TCTATATCCTGTACTATACCATTA") sequence repeated 25×. Although the hairpin loop structure was not experimentally isolated and sequenced, the comparison by clustalw2 alignment with the sequence of the termini of the ECTV-Moscow and ERPV genomes suggested that the genome was represented completely in the sequence, including the hairpin loop structures.

The 454-Roche sequencing output consisted of 92,155 reads with an average length of 360 bp ([Table 1](#t0005){ref-type="table"}). The 454-Roche reads were assembled into two contigs of approximately 35 Kbp and 163 Kbp, separated by the DRIII region. Sanger sequencing of a PCR product including the DRIII region also failed to determine the exact number of repeats. We estimated by gel electrophoresis of the PCR product the presence of 17 repeats of 24 bp in the DRIII region ([Fig. 1](#f0005){ref-type="fig"}). The genome sequence obtained by 454-Roche has a size of 204,205 bp, including a DRII region of 85 bp sequence repeated only 2.3× ([Table 1](#t0005){ref-type="table"}). The coverage of the genome was 83×, almost seven times higher than the coverage obtained by Sanger. This 454-Roche genome showed eight differences when compare to the genome obtained by Sanger, mostly due to A/T homopolymeric regions.

The genome sequence determined by Illumina was 207,620 bp long with a coverage of 1770×, which was 21 times and 147 times higher than those obtained by 454-Roche and Sanger sequencing, respectively ([Table 1](#t0005){ref-type="table"}). The genome determined by Illumina was identical in sequence to that obtained by Sanger.

In conclusion, the ECTV-Naval genome reported here corresponds to the genome sequence obtained by Sanger and Illumina, but considering the 17 repeated sequences in the DRIII region estimated by gel electrophoresis ([Fig. 1](#f0005){ref-type="fig"}). With a total size of 207,428 bp, this genome contains an ITR of 7377 bp and shows an A/T typical OPV composition of 66.87%.

Variability in the number of repeats in the DRIII region among ECTV isolates {#s0025}
----------------------------------------------------------------------------

Since the DRIII region appeared to be highly variable, we compared the length variation of this region in a collection of ECTV isolates available in our laboratory ([@bib52]): (i) ECTV-Moscow, plaque-purified from the virus isolated in an outbreak in Moscow in 1947 ([@bib7]); (ii) ECTV-Hampstead, the first ECTV isolated in 1930 from London ([@bib35]); (iii) ECTV Hampstead-Egg and ECTV-Mill Hill, derived from the ECTV Hampstead isolate by serial passage in eggs ([@bib52]); (iv) ECTV-Ishibashi, a plaque purified virus derived from an outbreak in Japan in 1966 ([@bib27]); (v) two isolates ECTV-MP1 (München, 1976) and ECTV-MP4 (Nürnberg, 1976) from German outbreaks ([@bib34; @bib40]); (vi) ECTV-MP5 from an outbreak in Wien (Austria) in 1994 ([@bib40]); and (vii) ECTV-Cornell isolated in the most recent outbreak in the USA ([@bib31]). A high variability in the number of repeats was detected among all the ECTV strains ([Fig. 1](#f0005){ref-type="fig"}) ranging from 15 repeats for ECTV Hampstead-Egg to 45 repeats estimated for ECTV-Cornell. Interestingly, different number of repeats were determined by PCR amplification followed by agarose gel analysis and by Sanger sequencing for ECTV-Naval (17 vs. 25 repeats, respectively) and for ECTV-Moscow (29 vs. 30 repeats, respectively) ([@bib14]). An alternative method to estimate the number of repeats in DRIII was to consider the number of Illumina sequencing reads aligned to this region compared to the number of sequencing reads in flanking non-repetitive regions of the genome. We estimated in this way the presence of 15 repeats in the DRIII region of the ECTV Naval genome, which was very close to the 17 repeats estimated by PCR amplification and agarose gel.

Annotation of the ECTV-Naval genome {#s0030}
-----------------------------------

Non-overlapping ORFs, with a minimum of 120 nt, encoding for proteins with similarity to a poxvirus ortholog of known function or conserved domains, were annotated as genes. Genes that were fragmented due to the presence of mutations, deletions or insertions that interrupted translation of the protein were designated as pseudogenes and named with a 'P'. Genes as well as pseudogenes were given a number according to their position in the genome ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}). A total of 206 putative genes were annotated in the ECTV-Naval genome: 174 genes and 32 pseudogenes. All genes shared more than 90% identity with the orthologs from the vaccinia virus strain Copenhagen (VACV-Cop), CPXV-BR or VARV-BSH reference genomes ([Table S1](#s0090){ref-type="sec"}). The genome of ECTV-Naval showed the typical poxviral genomic organization with essential genes in the central region of the genome and genes involved in virus-host interaction in the terminal regions of the genome.

The conserved region of the genome of ECTV-Naval includes essential genes that are involved in DNA replication and RNA transcription (47 genes) or morphogenesis (53 genes) ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}). It has been reported that 90 genes in the central region of VACV-Cop, from *F9L* to *A34R*, define the minimal gene content conserved in all the chordopoxvirus genera ([@bib1001]). These genes in the ECTV-Naval genome, from *EVN049* to *EVN156*, are conserved in VACV-Cop and VARV-BSH, with a few exceptions. For example, *EVN064* and *EVN136* are absent in VARV-BSH; *EVN147*, that encodes for the A-type inclusion body protein (ATIp), is present in CPXV-BR but fragmented in VACV-Cop and VARV-BSH; and *EVN148P*, a pseudogene of the *P4c* gene, is fragmented in CPXV-BR whereas it is a full-length gene in VACV-Cop and VARV-BSH ([Table S1](#s0090){ref-type="sec"}).

Genes that modulate the host immune system or determine the host range (42 genes) are located in the variable terminal regions of the genome ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}). These regions include genes encoding the viral growth factor, semaphorin homolog, ankyrin-like and kelch-like proteins involved in determining host range, inhibition of the ubiquitin proteasome system and apoptosis ([@bib48; @bib49]), and several secreted proteins which modulate inflammatory responses by sequestering cytokines such as receptor/binding proteins for chemokines, interleukin (IL)-1β, interferon (IFN)-α/β, IFN-γ and tumor necrosis factor (TNF) ([@bib2; @bib23; @bib32; @bib46; @bib50; @bib52; @bib53; @bib57; @bib58]) ([Table S1](#s0090){ref-type="sec"}). A total of 33 genes have no function ascribed ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}).

Seventeen pseudogenes are present in the right terminal region of the genome, 14 in the left terminal region and only one (*EVN148P*) in the central region of the genome ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}). Three genes and three pseudogenes are found in the ITR, which are consequently diploid. The duplicated genes encode for a chemokine binding protein (35 kDa), a TNF receptor/chemokine binding protein (Cytokine response modifier D, CrmD) and an ankyrin-like protein that blocks NF-*k*B activation ([@bib2; @bib23; @bib32; @bib44]). Interestingly, whereas CPXV encodes four TNF receptors (CrmB, CrmC, CrmD and CrmE), ECTV conserves only one functional protein, CrmD encoded by the *EVN006* gene, and the genes encoding CrmB, CrmE and CrmC are mutated, corresponding to pseudogenes *EVN002P*, *EVN005P* and *EVN175P*, respectively ([@bib3]) ([Fig. 2](#f0010){ref-type="fig"}, [Table S1](#s0090){ref-type="sec"}). The pseudogene *EVN007P* has not been fully duplicated laying in the intersection between the ITRs and the unique sequence.

Comparison with the ECTV-Moscow genome annotation showed several differences ([Tables S1 and S2](#s0090){ref-type="sec"}) ([@bib14]). The ECTV-Naval *EVN071* gene is a new ORF that was not annotated in the ECTV-Moscow genome. The ortholog of this novel gene in VACV-Cop, *O3L*, has been recently described to encode a small protein of 35 amino acids implicated in the formation of the entry/fusion complex ([@bib47]). The *EVN010P* pseudogene is formed by two fragments of the same gene that in ECTV-Moscow has been annotated as separate and independent gene ([@bib14]). These fragments show sequence similarity to the C-type lectin encoded by CPXV-Germany 91-3 (ABD97357) (data not shown). The truncated version of this protein in CPXV-BR, CPXV012, is responsible for down-regulation of major histocompatibility complex class I molecules ([@bib6; @bib12]). Despite sharing a 67% of amino acid sequence similarity with the first 46 amino acids of the CPXV012 protein, neither the truncated protein from ECTV-Moscow, nor the smaller protein from ECTV-Naval seem to be functional ([@bib6; @bib12]). The ortholog of *EVM144*, encoding a superoxide dismutase in VACV-Cop *A45R* ([@bib5; @bib13]) has lost 18 amino acids from its C-terminus in ECTV-Naval, and therefore has been annotated as pseudogene *EVN167P*. This truncation is due to the deletion of an adenine in a homopolymeric region that has been confirmed by the Sanger and Illumina sequencing. The ECTV-Naval gene *EVN019* codes for an IL-18 binding protein of 126 amino acids, whereas its ECTV-Moscow ortholog *EVM013* is 12 amino acids longer. The IL-18 binding protein encoded by both ECTV-Naval and ECTV-Moscow have been shown to be active ([@bib17; @bib52]). The ECTV-Naval *EVN038* gene, that codes for a DNAse with a size of 424 amino acids, is truncated (372 amino acids) in the ECTV-Moscow genome and it was annotated as a pseudogene (Region N) ([@bib14]). Differences between ECTV-Naval and ECTV-Moscow also include some amino acid mutations in a number of proteins ([Table S2](#s0090){ref-type="sec"}). In summary, the ECTV-Naval genome has 98.2% sequence identity with the ECTV-Moscow genome, and the predicted functional differences are limited to a shorter IL-18 binding protein (*EVN019*), a truncated superoxide dismutase (*EVN167P*) and a longer DNAse (*EVN038*) in ECTV-Naval, in addition to amino acid mutations in several proteins ([Tables S1 and S2](#s0090){ref-type="sec"}).

Unlike the recent ERPV annotation, but similar to the ECTV-Moscow annotation, we have annotated *EVN026P* and *EVN174P* as pseudogenes. *EVN026P* encodes only 106 amino acids of the 204 amino acids of its VACV-Cop ortholog *C5L*, having lost the kelch/BTB domain. This pseudogene is identical to that of ECTV-Moscow, annotated as 'Region I' and to the annotated gene *ERPV017* of ERPV. *EVN174P* is an ortholog of VACV-Cop *A52R*, an inhibitor of intracellular signaling mediated by IL-1, IL-18 and Toll-like receptors, and codes for a 33% smaller protein ([@bib8; @bib10; @bib25]) ([Table S1](#s0090){ref-type="sec"}).

The ECTV-Cornell genome: sequencing, annotation and comparison with the ECTV-Naval genome {#s0035}
-----------------------------------------------------------------------------------------

The ECTV-Cornell isolate, obtained from the Weill Medical College of Cornell University outbreak ([@bib31]), was not plaque-purified. The ECTV-Cornell genome was sequenced by the 454-Roche technology and, like the ECTV-Naval genome, was assembled into two contigs separated by the DRIII region consisting of 45 repeats of a 24 bp sequence, as estimated by gel electrophoresis ([Fig. 1](#f0005){ref-type="fig"}).

The ECTV-Cornell genome has a size of 204,499 bp with a coverage of 115×, including two copies of the 85 bp sequence of the DRII region ([Table 1](#t0005){ref-type="table"}). The initial annotation of the ECTV-Cornell revealed that three genes (*EVC019*, *EVC077* and *EVC133*) were interrupted due to incorrect estimation of the length of A/T homopolymers. PCR amplification of homopolymeric regions was carried out to determine the exact number of A/Ts and confirmed that full-length genes are also present in ECTV-Cornell (data not shown).

The ECTV-Naval and ECTV-Cornell genomes are almost identical to each other with a 99.9% identity, differing only in four positions of the genome ([Table 2](#t0010){ref-type="table"}); the number of 24 nt repeats determining a different number of "DIDNGIVQ" in the *EVN041*/*EVC041* genes, two single nt synonymous changes affecting genes *EVN160*/*EVC160* and *EVN165/EVC165*, and a different size in the homopolymer of the position 155,375 of the ECTV-Naval genome affecting the *EVN162P*/*EVC162P* pseudogenes. The ECTV-Naval and ECTV-Cornell genomes are very similar to the genome of ERPV, differing only in 12 positions, nine of which are affecting putative genes ([Table 2](#t0010){ref-type="table"}).

Virulence of ECTV-Naval and ECTV-Cornell {#s0040}
----------------------------------------

The virulence of ECTV-Naval and ECTV-Cornell in susceptible BALB/c mice was compared to that of ECTV-Moscow. Severe mousepox disease and death was caused by ECTV-Moscow, ECTV-Naval and ECTV-Cornell at 1 pfu per mouse indicating an LD~50~\<1 pfu ([Fig. 3](#f0015){ref-type="fig"}). The time of death (12--19 dpi) and weight loss (average of 7.2% at 9 dpi) were indistinguishable in mice infected with these viruses. All mice suffered severe signs of illness (hunched posture, conjunctivitis and reduced mobility) but limited foot swelling was observed. With higher doses of 10 and 10^2^ pfu per mouse, mortality and disease progression were similar but foot swelling started 1--2 days earlier in mice infected with ECTV-Moscow. Footpad infection of susceptible DBA/2 mice with 0.1, 1, 10 and 10^2^ pfu of ECTV-Naval or ECTV-Moscow showed a LD~50~\<1 pfu for both viruses (data not shown).

Discussion {#s0045}
==========

ECTV is the causal agent of mousepox, an OPV infection of mice that affected animal facilities in Europe, Asia and USA during the past century. ECTV-Naval and ECTV-Cornell are isolates that caused two separate outbreaks in laboratory mouse colonies in USA. We report the genomic sequence of ECTV-Naval, sequenced with three different technologies (Sanger, 454-Roche and Illumina), and ECTV-Cornell, sequenced with 454-Roche.

The complete genome sequence of ECTV-Naval obtained with the Sanger method or Illumina sequencing were identical, whereas the 454-Roche technology failed to determine the exact number of nt in homopolymers of more than six consecutive A/T bases. Several of these errors in homopolymers caused the introduction of early stop codons in some ORFs. The need to correct these errors by further steps of PCR amplifications and Sanger sequencing limits the use of the 454-Roche technology for *de novo* sequencing or re-sequencing of OPV genomes or any other genome with a high A/T content. We concluded that Illumina appears to be a more solid technology, in terms of quality and cost-benefit when sequencing poxvirus genomes with a close reference genome available. It has been proposed that the 454-Roche technology might be a better choice for *de novo* assembly of poxviral genomes without a related reference genome, due to the longer sequences obtained. However, the recent increase in read length attained with the Miseq platform (2×300 bp), together with its higher coverage, will make this technology most suitable for *de novo* assembly of large viral genomes.

Nevertheless, we found that Sanger, 454-Roche and Illumina present a common limitation. These three technologies are not able to determine the exact number of repeated sequences that cover a portion of the genome larger than the average size of the output reads. To solve this problem we performed a gel electrophoresis estimation of the length of the PCR products and it revealed a high variability in the number of repeats among all the ECTV strains, whereas only a few copies are present in VACV and CPXV ([@bib59]). It is unlikely that these repeats have originated artificially during the Phi29 polymerase amplification step in library production because they were found in the genomes of ECTV sequenced by Sanger: ECTV-Naval (this publication) and ECTV-Moscow ([@bib14]). This variability is likely due to a DNA polymerase slippage event occurring during viral DNA replication, normally described for short tandem repeats of three bases but also possible for longer sequences ([@bib54]). This viral DNA polymerase slippage could explain the high variability in the number of repeats found in different ECTV isolates or virus stocks. Indeed, the ECTV-Naval and ECTV-Moscow DNA template used for the Sanger sequencing of the genomes (25 and 30 repeats, respectively) and those used for the PCR gel estimation (17 and 29 repeats, respectively) derived from distinct viral amplifications. A mixture of genomes with different number of repeats was even observed within the same virus stock in our gel analysis of PCR products. The repeats are located within the *EVN041* gene, the ortholog of VACV-Cop *F1L*, and encode numerous reiterations of eight amino acids ("DIDNGIVQ"). Despite this variation in protein length the crystal structure of VACV-Cop F1 indicates that the structural determinants essential for the inhibition of caspase 9 are preserved, and that even if 45 repeats of "DIDNGIVQ" are present, as for ECTV-Cornell, the protein may be active ([@bib59]).

In order to ensure that genes were correctly annotated, we have taken into account recently published data describing novel gene functions, such as the VACV-Cop O3 protein, a component of the entry/fusion complex ([@bib47]), or recently defined structural domains, such as the VACV-Cop F1 protein ([@bib59]). ORFs with mutations that cause the loss of an initiator methionine or the introduction of stop codons and frameshifts leading to the fragmentation of genes otherwise active in other poxviruses were annotated as pseudogenes. These fragmented genes are often found in viral genomes, probably reflecting that the mutations were introduced recently during evolution. This common phenomenon in OPV genomes leads to the identification of small ORFs that correspond to fragments of the active gene or new ORFs derived from translation of an alternative reading frame, even in the reverse orientation to the original gene. The latter is very often misleading because it may be interpreted as the presence of a new gene in a particular virus whereas the reality is that a genuine gene located in that position is fragmented. Pseudogenes highlight the absence of an active gene, information that may be relevant to evaluate the contribution of such gene to viral pathogenesis. Pseudogenes were only annotated when there was clear evidence for the existence of the active ortholog gene, either from comparative analysis of other poxvirus genomes and/or from functional data available in the published literature. When this was not clear or the genes were truncated and could still retain activity, they were annotated as genes. We have named pseudogenes with the corresponding order gene number and added the letter 'P' to distinguish them from genes and to simplify a possible change of pseudogene to gene, if its functionality is demonstrated in the future. We believe that this annotation will provide a better interpretation of the coding capacity of poxvirus genomes.

The ECTV-Naval and ECTV-Cornell genomes are almost identical, differing in four silent mutations and in the number of the 24 nt direct repeats. The number of repeats is unlikely to contribute to virulence since they can vary even between stocks of the same ECTV. Moreover, the in vivo experiments showed an LD~50~\<1 pfu per mouse for both ECTV-Naval and ECTV-Cornell in BALB/c mice. In light of these results, it is conceivable that ECTV-Naval and ECTV-Cornell are the same virus. Further evidence supporting this hypothesis is that the outbreak at Cornell University was caused by the injection of mice with a contaminated commercial serum imported in 1995 from China, the same year the outbreak occurred in the Naval Medical Research Institute, associated also with the use of a contaminated mouse serum ([@bib15; @bib30]). This suggests that both outbreaks were caused by the same ECTV present in the mouse serum batch imported to the USA at that time. ECTV-Naval shares a 99.8% nucleotide identity with ERPV ([@bib39]). The similarity of ERPV to ECTV-Naval, together with the origin of the mouse imported serum, indicate that these viruses originated in China and support the presence of an ECTV reservoir in that country. Several records describing ERPV mention the existence of a previous Chinese ECTV from the early 1960s and at least six isolates of ERPV have been described ([@bib60; @bib61]).

Materials and methods {#s0050}
=====================

Cells and viruses {#s0055}
-----------------

Monkey kidney BS-C-1 cells (ATCC: CCL-26) were grown in Dulbecco׳s modified Eagle׳s medium supplemented with 10% heat-inactivated fetal bovine serum (Gibco BRL). Plaque-purified ECTV-Moscow-3-P2 (ECTV-Moscow) ([@bib14]), derived from the original stock of F. Fenner ([@bib7]), and ECTV-Naval, the original stock of the Naval Medical Research Institute outbreak (Bethesda, Maryland, USA) ([@bib15]), were provided by R. M. L. Buller (School of Medicine, Saint Louis University). Plaque-purified ECTV-Naval.Cam was derived from ECTV-Naval as follows. A BALB/c mouse was infected with ECTV-Naval and 7 days after infection the spleen was homogenized and several dilutions plated on BS-C-1 cell monolayers. A virus plaque was clonally isolated through three rounds of plaque purification on BS-C-1 cells obtaining ECTV-Naval.Cam. ECTV-Naval.Cam is referred in the text as ECTV-Naval. ECTV-Cornell isolated from the Weill Medical College of Cornell University outbreak ([@bib31]) was provided by H. Meyer (Institute of Microbiology, Federal Armed Forces Medical Academy, Munich, Germany) and N. Lipmann (Weill Medical College of Cornell University, New York, N.Y.). The source of the ECTV isolates Hampstead, Hamstead-Egg, Mill-Hill, Ishibashi, MP1, MP4 and MP5 are described elsewhere ([@bib52]).

Viral stocks for animal experiments and isolation of DNA were obtained from semi-purified viral particles. Briefly, BS-C-1 cells were infected at a multiplicity of infection of 0.01 plaque forming units (pfu) per cell and homogenized by serial syringe passages. Nuclei and cell debris were discarded by centrifugation at 900*g* for 10 min at 4 °C, and viral particles were isolated by ultracentrifugation at 20,000*g* for 1 h at 4 °C through a 36% sucrose cushion and resuspended in 10 mM Tris pH 9.

Isolation of viral DNA {#s0060}
----------------------

Free DNA from semi-purified viral stocks was digested with DNAse I (500  Units/ml) (Roche), Nuclease S7 Micrococcal (500 Units/ml) (Roche) and RNAse A (20 μg/ml) (Roche). After proteinase K (200 μg/ml) (Invitrogen) and 0.5% sodium dodecyl sulfate treatment, viral DNA was extracted with phenol/chloroform and precipitated with 0.1 volume of 3 M sodium acetate pH 5.3 and 2.5 volumes of ethanol in the presence of 10 μg/ml of oyster glycogen (Roche) as carrier. In the case of 454-Roche and Illumina sequencing, viral DNA was subsequently purified by gel electrophoresis with 1% low melting agarose (MicroSieve Clone LM agarose, Flowgen Bioscience) and extracted with the QIAquick Gel Extraction Kit (Qiagen), and purified viral DNA was amplified by multiple displacement amplification using Phi29 DNA Polymerase as described by the manufacturer (Illustra GenomiPhi V2 DNA Amplification Kit; GE Healthcare). Phi29-amplified viral DNA was precipitated with ethanol in order to minimize the primer contamination.

Genome sequencing and assembly {#s0065}
------------------------------

For Sanger sequencing, purified viral genome was fragmented by shotgun and fractions ranging from 1.4 to 2 Kbp were cloned into pUC18 vector. Random sub-clones were sequenced using dye-terminator chemistry on ABI 377 automated sequencers at the Wellcome Trust Sanger Institute (Hinxton, United Kingdom). The entire sequence was read on both strands and the genome was assembled with PHRAP/GAP4 (<http://www.phrap.org/>) ([@bib9]). For 454-Roche sequencing, 2 μg of the Phi29-amplified viral DNA was used for the construction of a library using 454-Roche GS-FLX Titanium system (454 Life Sciences, Roche). Sequencing reads obtained with a FLX Genome Sequencer in the Parque Científico de Madrid were assembled in three steps with Newbler 2.5.3 (Roche). First, using the GS Reference *Mapper* the reads were aligned to the ECTV-Naval genome obtained by Sanger as reference under the parameters: 90% minimum overlap and 95% identity. Second, a *de novo* assembly was carried out with GS De Novo *Assembler* under more stringent parameters (90% bases overlap and 97% overlap identity) in order to determine the inverted terminal repeat (ITR) regions. Finally, a second mapping was carried out at 97% of identity in at least 90% of the sequence length. For Illumina sequencing, 5 μg of the Phi29-amplified viral DNA were used for the construction of a TruSeq library. Reads obtained with a Genome Analyzer IIx in the Parque Científico de Madrid were mapped using the trial version of CLC-Genomics Workbench 5.5.1 (CLC bio) to the Sanger ECTV-Naval genome as reference under the following parameters: 90% length overlap and 95% similarity.

Analysis of fragment size by gel electrophoresis {#s0070}
------------------------------------------------

A PCR amplification of the region containing the central direct repeat (DRIII) ([@bib39]) was carried out with the primers forward (5′-CCCGTTCCGTTGATAGAT-3′) and reverse (5′-GGAAGAAGTACAATCTCTA-3′). The PCR product was run in a 2% agarose gel with a 100 bp ladder (Invitrogen) as marker. The most intense band of each isolate was considered for the estimation of the number of repeats. The sources of ECTV isolates used as templates have been previously described ([@bib52]).

Genome analysis and annotation {#s0075}
------------------------------

The genomes were annotated using Artemis (Wellcome Trust Sanger Institute) ([@bib45]). Percentages of identity and number of different nucleotides (nt) between the genomes were obtained by full-length genome alignment using Geneious Pro 6.1 (Biomatters). Open reading frames (ORFs) that code for non-overlapping proteins with a minimum 120 nt, with similarity to a poxvirus ortholog of known function or with preserved domains were annotated as genes. Fragmented genes, generated by deletion or insertion, with similarity to poxvirus functional orthologs were annotated as pseudogenes. Genes and pseudogenes were named with a three letter acronym EVN or EVC (the first two letters standing for ECTV and the third letter indicating the initial of the Naval or Cornell isolate) and numbered consecutively from left to right region of the genome. Pseudogenes were indicated with a P after the number. The schematic representation of the ECTV-Naval genome was designed with the Artemis DNAPlotter and refined manually.

Experimental infection of susceptible BALB/c and DBA/2 mice {#s0080}
-----------------------------------------------------------

Groups of five female BALB/c and DBA/2 mice, six to seven weeks old, were purchased from Charles River Laboratories, anesthetized using isoflurane and infected subcutaneously in the left hind footpad with 1, 10 or 10^2^ pfu of semi-purified ECTV-Naval, ECTV-Cornell, ECTV-Moscow or PBS as control. Clinical signs of illness and body weight loss were monitored daily for 19 days post-infection (dpi). Mice were housed under biological safety level 3 in a ventilated rack (Allentown) with free access to food and water and 12 h light/12 h dark cycle. Animal experiments were approved by the Ethical Committee of the Consejo Superior de Investigaciones Científicas and the Biological Safety Department of the Centro de Biología Molecular Severo Ochoa, and carried out according to European regulations.

Nucleotide sequence accession number {#s0085}
====================================

The genome sequence of ECTV-Naval was submitted to GenBank with the accession number KJ563295.

Appendix A. Supporting information {#s0090}
==================================

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.virol.2014.06.010](http://dx.doi.org/10.1016/j.virol.2014.06.010){#ir0010}.
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![Variability of the DRIII region among ECTV strains. (A) The locations of the DRI, DRII and DRIII regions in the schematic representation of the ECTV genome are shown. The DRIII region was PCR-amplified from genomic DNA and analyzed by 2% agarose gel electrophoresis. Molecular size markers (Ladder) are shown. (B) The estimated number of 24 bp repeats for each ECTV strain is shown. H, ECTV-Hampstead; HE, ECTV-Hampstead Egg; I, ECTV-Ishibashi; MH, ECTV-Mill Hill; M1, ECTV-MP1; M4, ECTV-MP4; M5, ECTV-MP5; C, ECTV-Cornell; N, ECTV-Naval; M, ECTV-Moscow.](gr1){#f0005}

![Schematic organization of the ECTV-Naval genome. Predicted putative genes are represented as arrows indicating the approximate size and direction of transcription. The color of the arrows indicate the predicted function: red, immunomodulatory and host range; yellow, metabolism; orange, structural proteins and morphogenesis; brown, unknown function. Pseudogenes are indicated as dark gray rectangles. ITRs are marked as a green line.](gr2){#f0010}

![Virulence of the ECTV-Moscow, ECTV-Naval and ECTV-Cornell isolates in BALB/c mice. Groups of five female 5--6 week old mice were subcutaneously infected in the footpad with different doses of ECTV-Moscow (A), ECTV-Naval (B) or ECTV-Cornell (C) (1, 10 and 10^2^ pfu per mouse). Mortality (%), weight (%), swelling of the foot (mm) and signs of illness are represented.](gr3){#f0015}

###### 

DNA sequencing of the ECTV-Naval and the ECTV-Cornell genomes.

                                                                      ECTV-Naval   ECTV-Cornell               
  ------------------------------------------------------------------- ------------ -------------- ----------- ---------
  Total reads                                                         5810         92,155         5,497,834   67,965
  Mapped reads (%)[a](#tbl1fna){ref-type="table-fn"}                  nd           45,195         4,835,589   58,558
  (49.0%)                                                             (87.9%)      (86.1%)                    
  Average reads size (bp)                                             536          360            76          384
  Genome coverage (x)                                                 13           83             1770        115
  Genome size (bp)                                                    207,620      204,099        207,620     204,499
  Differences with Sanger genome [b](#tbl1fnb){ref-type="table-fn"}   --           8              0           nd

nd, not determined.

Number of reads mapped to the reference viral genome .

Number of nucleotide differences as compared to the Sanger genome.

###### 

Differences among the genomes of ECTV-Naval, ECTV-Cornell and ERPV.

  **Position in ECTV-Naval**   **ORF**   **ECTV-Naval**   **ECTV-Cornell**   **ERPV**   **Amino acid differences**
  ---------------------------- --------- ---------------- ------------------ ---------- -------------------------------
  36,910                       EVN041    17×24 pb         45×24 pb           7×24 pb    Variable number of "DIDNGIVQ"
  55,612--55,613               EVN062    --               --                 AT         10 aa N-terminal deletion
  130,142                      EVN081    T                T                  C          V66A
  127,552                      EVN131    A                A                  G          R236G
  125,616                      EVN131    T                T                  C          V881A
  152,911                      EVN160    T                C                  C          --
  155,375                      EVN162P   11×C             9×C                7×C        --
  158,361                      EVN165    G                T                  G          --
  159,104                      EVN166P   5×A              5×A                6×A        --
  159,383                      EVN167    T                T                  C          S67P
  167,577                      EVN176    A                A                  G          N358D
  168,661                      EVN177    T                T                  G          Y139D
  189,833                      EVN196    A                A                  G          M241V

[^1]: Present address: Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL 32610-3663, USA.

[^2]: Present address: Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk CB8 7UU, United Kingdom.
